Inventor · Mansfield, MA, US

William Brondyk

19Patents
2h-index
37Co-inventors
54Inventor score

Filing activity: Oct 22, 2002 → Jan 23, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US8617554B2 Anti-human CD52 immunoglobulins Chemistry; Metallurgy 8 Active
US10626169B2 Multispecific binding molecules having specificity to dystroglycan and laminin-2 Chemistry; Metallurgy 7 Active
US11498953B2 Compositions for increasing half-life of a therapeutic agent in felines and methods of use Chemistry; Metallurgy 2 Active
US7317095B2 Mutant glycoproteins Human Necessities 2 Expired
US11739135B2 Compositions for increasing half-life of a therapeutic agent in felines and methods of use Chemistry; Metallurgy 1 Active
US9567382B2 Methods to produce rod-derived cone viability factor (RdCVF) Human Necessities 1 Active
US7700112B2 FSH beta mutants that are glycosilated at residues N55 and T57 Human Necessities 1 Active
US11254737B2 Multispecific binding molecules having specificity to dystroglycan and laminin-2 Chemistry; Metallurgy 0 Active
US12344650B2 Compositions for increasing half-life of a therapeutic agent in felines and methods of use Chemistry; Metallurgy 0 Active
US11542333B2 Compositions for increasing half-life of a therapeutic agent in canines and methods of use Chemistry; Metallurgy 0 Active
US7258997B2 Methods of increasing protein expression levels Emerging Cross-Sectional Technologies 0 Expired
US11505611B2 FGFR3 antibodies and methods of use Emerging Cross-Sectional Technologies 0 Active
US12103961B2 Compositions for increasing half-life of a therapeutic agent in livestock animals and methods of use Emerging Cross-Sectional Technologies 0 Active
US11945874B2 Anti-human CD52 immunoglobulins Chemistry; Metallurgy 0 Active
US11434276B2 Polypeptides with altered binding to neonatal Fc receptor (FcRn) and methods of use Chemistry; Metallurgy 0 Active
US10035829B2 Methods to produce rod-derived cone viability factor (RDCVF) Human Necessities 0 Active
US12110322B2 Anti-NGF antibodies and uses thereof Chemistry; Metallurgy 0 Active
US12378308B2 Anti-NGF antibodies and uses thereof Chemistry; Metallurgy 0 Active
US11548949B2 Compositions for increasing half-life of a therapeutic agent in canines and methods of use Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.